Literature DB >> 12972030

The importance of PU.1 concentration in hematopoietic lineage commitment and maturation.

Richard Dahl1, M Celeste Simon.   

Abstract

PU.1 is an Ets family transcription factor that is required for the development of myeloid and lymphoid cells. Since PU.1 is required for several different lineages it has been unclear what role PU.1 has in deciding whether a hematopoietic progenitor cell differentiates into a macrophage, granulocyte, or B cell. Recent studies have demonstrated that different cellular concentrations of PU.1 may direct distinct cell fates, with the highest concentrations of PU.1 required for macrophage development and lower concentrations for granulocytic and B-cell fate adoption. Since PU.1 transactivation activity is inhibited by the granulocytic factor, C/EBPalpha and the B-cell factor BSAP, high concentrations of PU.1 may be required for macrophage development in order to overcome the negative effects of alternative lineage specific factors. Lastly, PU.1 upregulation is implicated in the maturation of myeloid cells once they have committed to the macrophage and granulocytic lineages. PU.1 activity is inhibited in some cases of acute myelogenous leukemia (AML), therefore, inhibition of PU.1 induced maturation may be a critical step in leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972030     DOI: 10.1016/s1079-9796(03)00152-9

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  28 in total

1.  Functional PU.1 in macrophages has a pivotal role in NF-κB activation and neutrophilic lung inflammation during endotoxemia.

Authors:  Manjula Karpurapu; Xuerong Wang; Jing Deng; Hyesuk Park; Lei Xiao; Ruxana T Sadikot; Randall S Frey; Ulrich A Maus; Gye Young Park; Edward W Scott; John W Christman
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

Review 2.  Role of Kruppel-like factors in leukocyte development, function, and disease.

Authors:  Zhuoxiao Cao; Xinghui Sun; Basak Icli; Akm Khyrul Wara; Mark W Feinberg
Journal:  Blood       Date:  2010-07-08       Impact factor: 22.113

3.  Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages.

Authors:  Martina I Lefterova; David J Steger; David Zhuo; Mohammed Qatanani; Shannon E Mullican; Geetu Tuteja; Elisabetta Manduchi; Gregory R Grant; Mitchell A Lazar
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

4.  Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR.

Authors:  Luigi Warren; David Bryder; Irving L Weissman; Stephen R Quake
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-10       Impact factor: 11.205

5.  Ski can negatively regulates macrophage differentiation through its interaction with PU.1.

Authors:  N Ueki; L Zhang; M J Hayman; M J Haymann
Journal:  Oncogene       Date:  2007-07-09       Impact factor: 9.867

6.  Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c.

Authors:  Sandra Stehling-Sun; Jessica Dade; Stephen L Nutt; Rodney P DeKoter; Fernando D Camargo
Journal:  Nat Immunol       Date:  2009-01-25       Impact factor: 25.606

Review 7.  Signatures of DNA target selectivity by ETS transcription factors.

Authors:  Gregory M K Poon; Hye Mi Kim
Journal:  Transcription       Date:  2017-03-16

Review 8.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

9.  Treatment effect of low intensity pulsed ultrasound on leukopenia induced by cyclophosphamide in rabbits.

Authors:  Baoru Liu; Yueping Luo; Dong Luo; Weichen Zhou; Yu Zhang; Ruixin He; Junshu Li; Yong Wang; Yan Wang; Wenzhi Chen
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 10.  Signal transduction of oncogenic Flt3.

Authors:  Chunaram Choudhary; Carsten Müller-Tidow; Wolfgang E Berdel; Hubert Serve
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.